seen from United States
seen from Austria
seen from Austria
seen from Israel
seen from China
seen from China
seen from United States
seen from United States
seen from United States
seen from United States
seen from Italy
seen from France
seen from China
seen from China
seen from China
seen from United States
seen from Türkiye
seen from Singapore
seen from China
seen from Syria
The high potent API market is experiencing steady expansion as drug development strategies increasingly emphasize targeted and high-efficacy therapies. The market is projected to grow from US$ 28.82 billion in 2024 to US$ 50.01 billion by 2031, recording a CAGR of 8.3% during the forecast period.
